{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:41:21Z","timestamp":1760924481251,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,7,14]],"date-time":"2018-07-14T00:00:00Z","timestamp":1531526400000},"content-version":"am","delay-in-days":378,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.biologicals.2017.05.001","type":"journal-article","created":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T09:01:30Z","timestamp":1495530090000},"page":"92-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Scientific consultation on the safety and containment of new poliovirus strains for vaccine production, clinical\/regulatory testing and research. Report of a meeting held at NIBSC, Potters Bar, Hertfordshire, UK, 6\/7th July 2016"],"prefix":"10.1016","volume":"48","author":[{"given":"Philip D.","family":"Minor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blanche","family":"Lane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"South","family":"Mimms","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Potters","family":"Bar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2017.05.001_bib1","unstructured":"Status of polio eradication: http:\/\/polioeradication.org\/polio-today\/polio-now\/this-week\/(Accessed 25 November 2016)."},{"key":"10.1016\/j.biologicals.2017.05.001_bib2","unstructured":"HSE guidance on risk assessment for biological agents:http:\/\/www.hse.gov.uk\/biosafety\/information.htm (Accessed 20 January 2017)."},{"key":"10.1016\/j.biologicals.2017.05.001_bib3","unstructured":"http:\/\/polioeradication.org\/wp-content\/uploads\/2016\/09\/GAPIII_2014.pdf (Accessed 25 November 2016)."},{"key":"10.1016\/j.biologicals.2017.05.001_bib4","unstructured":"http:\/\/polioeradication.org\/wp-content\/uploads\/2016\/07\/PEESP_EN_A4.pdf (accessed 20th 424 January 2107)."},{"key":"10.1016\/j.biologicals.2017.05.001_bib5","unstructured":"Certification scheme for compliance with GAPIII http:\/\/polioeradication.org\/wp426content\/uploads\/2016\/10\/CCS.pdf (Accessed 25 November 2016)."},{"key":"10.1016\/j.biologicals.2017.05.001_bib6","first-page":"335","article-title":"Antiviral activity of pocapavir in a randomized, blinded, placebo-controlled human oral poliovirus vaccine challenge model","volume":"215","author":"Collett","year":"2017","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.biologicals.2017.05.001_bib7","unstructured":"Code of Federal Regulations requirements for Immune globulin http:\/\/www.ecfr.gov\/cgi432bin\/retrieveECFR?gp=1&SID=a8774c25fc4bccb08409f459f093639f&h=L&mc=true&n=sp21.7.640.j&r=SUBPART&ty=HTML (Accessed 20 January 2017)."},{"issue":"17","key":"10.1016\/j.biologicals.2017.05.001_bib8","doi-asserted-by":"crossref","first-page":"8653","DOI":"10.1128\/JVI.00370-06","article-title":"Rational design of genetically stable, live attenuated poliovirus vaccines of all three serotypes: relevance to poliomyelitis eradication","volume":"80","author":"Macadam","year":"2006","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.biologicals.2017.05.001_bib9","doi-asserted-by":"crossref","first-page":"9957","DOI":"10.1128\/JVI.00508-09","article-title":"Genetic inactivation of poliovirus infectivity by increasing the frequencies of CpG and UpA dinucleotides within and across synonymous capsid region codons","volume":"83","author":"Burns","year":"2009","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.biologicals.2017.05.001_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005483","article-title":"Cold-adapted viral attenuation (CAVA): highly temperature sensitive polioviruses as novel vaccine strains for a next generation inactivated poliovirus vaccine","author":"Sanders","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.biologicals.2017.05.001_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005316","article-title":"New strains intended for the production of inactivated polio vaccine at low-containment after eradication","author":"Knowlson","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.biologicals.2017.05.001_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006117","article-title":"Genetically thermo-stabilised, immunogenic poliovirus empty capsids; a strategy for non-replicating vaccines","author":"Fox","year":"2017","journal-title":"PLoS Pathog"},{"issue":"11","key":"10.1016\/j.biologicals.2017.05.001_bib13","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1128\/CVI.05225-11","article-title":"Development 451 of a poliovirus neutralization test with poliovirus pseudovirus for measurement of neutralizing antibody titer in human serum","volume":"18","author":"Arita","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"8","key":"10.1016\/j.biologicals.2017.05.001_bib14","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1128\/JCM.00207-10","article-title":"Development of a particle agglutination method with soluble virus receptor for identification of poliovirus","volume":"48","author":"Arita","year":"2010","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.biologicals.2017.05.001_bib15","doi-asserted-by":"crossref","unstructured":"Holland,JJ, McLaren, LC, Syverton,JT. The mammalian cell virus relationship iv. Infection of naturally insusceptible cells with enterovirus ribonucleic acid. J Exp Med; 110(1): 65\u201380.","DOI":"10.1084\/jem.110.1.65"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105617300593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105617300593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:13:04Z","timestamp":1760922784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105617300593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":15,"alternative-id":["S1045105617300593"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2017.05.001","relation":{},"ISSN":["1045-1056"],"issn-type":[{"type":"print","value":"1045-1056"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Scientific consultation on the safety and containment of new poliovirus strains for vaccine production, clinical\/regulatory testing and research. Report of a meeting held at NIBSC, Potters Bar, Hertfordshire, UK, 6\/7th July 2016","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2017.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ltd on behalf of International Alliance for Biological Standardization.","name":"copyright","label":"Copyright"}]}}